Atazanavir is not associated with an increased risk of cardio- or cerebrovascular disease events

Authored by: D’Arminio Monforte Antonella, Reiss Peter, Ryom Lene, El-Sadr Wafaa, Dabis Francois, de Wit Stephane, Worm Signe W., Law Mathew G., Weber Rainer, Kirk Ole, Pradier Christian, Phillips Andrew N., Lundgren Jens D., Sabin Caroline A.
In: AIDS 27(3), 2013, p.407-415
http://www.ncbi.nlm.nih.gov/pubmed/23291539